Most Accessed Articles


Towards Prevention of Ovarian Cancer

, 2018; 18(6): 522-537.

Aus Tariq Ali*


DOI: 10.2174/1568009618666180102103008



Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation

, 2003; 3(1): 1-19.

R. Z. Yusuf, Z. Duan, D. E. Lamendola, R. T. Penson and M. V. Seiden


DOI: 10.2174/1568009033333754



HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles

, 2017; 17(7): 637-649.

Sarah L. Sammons, Donna L. Topping and Kimberly L. Blackwell*


DOI: 10.2174/1568009617666170330120452



A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer

, 2015; 15(8): 665-683.

Otília Menyhart, Libero Santarpia and Balazs Gyorffy


DOI: 10.2174/156800961508151001101742



The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy

, 2009; 9(1): 32-71.

Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti and Massimino D'Armiento


DOI: 10.2174/156800909787314002



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science